Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLong-Term Debt IssuancesPreferred Shares RepurchasedReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Metlife (MET) EBIAT (2016 - 2025)

Metlife (MET) has 17 years of EBIAT data on record, last reported at -$2.4 billion in Q3 2025.

  • For Q3 2025, EBIAT fell 278.98% year-over-year to -$2.4 billion; the TTM value through Sep 2025 reached $585.0 million, down 84.38%, while the annual FY2024 figure was $4.4 billion, 181.62% up from the prior year.
  • EBIAT reached -$2.4 billion in Q3 2025 per MET's latest filing, down from $735.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $3.4 billion in Q2 2021 and bottomed at -$2.4 billion in Q3 2025.
  • Average EBIAT over 5 years is $904.1 million, with a median of $950.0 million recorded in 2025.
  • Peak YoY movement for EBIAT: surged 2171.33% in 2021, then plummeted 278.98% in 2025.
  • A 5-year view of EBIAT shows it stood at $1.2 billion in 2021, then grew by 28.42% to $1.6 billion in 2022, then tumbled by 62.37% to $590.0 million in 2023, then skyrocketed by 116.1% to $1.3 billion in 2024, then tumbled by 286.27% to -$2.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$2.4 billion in Q3 2025, $735.0 million in Q2 2025, and $950.0 million in Q1 2025.